Systemic lupus erythematosus: Association with KIR and SLC11A1 polymorphisms,ethnic predisposition and influence in clinical manifestations at onset revealed by ancestry genetic markers in an urban Brazilian population
Restricted accessResearch articleFirst published online March, 2011
Systemic lupus erythematosus: Association with KIR and SLC11A1 polymorphisms,ethnic predisposition and influence in clinical manifestations at onset revealed by ancestry genetic markers in an urban Brazilian population
Systemic lupus erythematosus (SLE) is an autoimmune disorder of the connective tissue with a wide and heterogeneous spectrum of manifestations, with renal and neurological involvement usually related to worse prognosis. SLE more frequently affects females of reproductive age, and a high prevalence and renal manifestation seem to be associated with non-European ethnicity. The present study aims to investigate candidate loci to SLE predisposition and evaluate the influence of ethnic ancestry in the disease risk and clinical phenotypic heterogeneity of lupus at onset. Samples represented by 111 patients and 345 controls, originated from the city of Belém, located in the Northern Region of Brazil, were investigated for polymorphisms in HLA-G, HLA-C, SLC11A1, MTHFR, CASP8 and 15 KIR genes, in addition to 89 Amerindian samples genotyped for SLC11A1. We also investigated 48 insertion/deletion ancestry markers to characterize individual African, European and Amerindian ancestry proportions in the samples. Predisposition to SLE was associated with GTGT deletion at the SLC11A1 3’UTR, presence of KIR2DS2 +/KIR2DS5 +/KIR3DS1 + profile, increased number of stimulatory KIR genes, and European and Amerindian ancestries. The ancestry analysis ruled out ethnic differences between controls and patients as the source of the observed associations. Moreover, the African ancestry was associated with renal manifestations.
FontJCerveraRRamos-CasalsM. Clusters of clinical and immunologic features in systemic lupus erythematosus: analysis of 600 patients from a single center. Semin Arthritis Rheum2004; 33: 217–230.
2.
Alarcon-SegoviaDAlarcon-RiquelmeM. Etiopatogenesis of systemic lupus erythematosus. In: LahitaRG (ed.), Systemic Lupus Erythematosus. New York: Academic Press,; 2004. 93–107.
3.
DeapenDEscalanteAWeinribL. A revised estimate of twin concordance in systemic lupus erythematosus. Arthritis Rheum1992; 35: 311–318.
4.
CrokerJAKimberlyRP. Genetics of susceptibility and severity in systemic lupus erythematosus. Curr Opin Rheumatol2005; 17: 529–537.
5.
HarleyCDPankeyMSWaresJPGrosbergRKWonhamMJ. Color polymorphism and genetic structure in the sea star Pisaster ochraceus. Biol Bull2006; 211: 248–262.
6.
BarcelosLFMaySLRamsayPP. High density SNP screening of major histocompatibility complex in systemic lupus erythematosus demonstrate strong evidence for independent susceptibility regions. PLoS Genetics2009; 5: 1–10.
7.
LeeYHNathSK. Systemic lupus erythematosus susceptibility loci defined by genome scan meta-analysis. Hum Genet2005; 118: 434–443.
8.
HanJZhengHCuiY. Genome-wide association study in a Chinese Han population identifies nine new susceptibility loci for systemic lupus erythematosus. Nature Genetics2009; 41: 1234–1237.
9.
LuLJWallaceDJIshimoriMLScofieldRHWeismanMH. Male systemic lupus erythematosus: a review of sex disparities in this disease. Lupus2010; 19: 119–129.
10.
Pons-EstelGJAlarcónGSAlarcónGSScofieldLReinlibLCooperGS. Understanding the epidemiology and progression of systemic lupus erythematosus. Semin Arthritis Rheum2010; 39: 257–268.
11.
MolokhiaMMckeigueP. Risk for rheumatic disease in relation to ethnicity and admixture. Arthritis Res2000; 2: 115–125.
12.
MolokhiaMHoggartsCPatrickAL. Relation of risk of systemic lupus erythematosus to West African admixture in a Caribbean population. Hum Genet2003; 112: 310–318.
13.
PeschkenCAKatzSJSilvermanE. Canadian Network for Improved Outcomes in Systemic Lupus Erythematosus (CaNIOS). The 1000 Canadian faces of lupus: determinants of disease outcome in a large multiethnic cohort. J Rheumatol2009; 36: 1200–1208.
AlarcónGSMcGwinGJrBartolucciAA. Lupus in minority populations, nature versus nurture. Systemic lupus erythematosus in three ethnic groups. IX. Differences in damage accrual. Arthritis Rheum2001; 44: 2797–2806.
16.
LindqvistBASteinssonKJohannesonB. A susceptibility locus for human systemic lupus erythematosus (hSLE1) on chromosome 2q. J Autoimmun2000; 14: 169–178.
17.
BarretoMSantosEFerreiraR. Evidence for CTLA4 as a susceptibility gene for systemic lupus erythematosus. Eur J Hum Genet2004; 12: 620–626.
18.
Quintero-Del-RioAKellyJAKilpatrickJJamesJÁHarleyJB. The genetics of systemic lupus erythematosus stratified by renal disease: linkage at 10q22.3 (SLEN1), 2q34–35 (SLEN2), and 11p15.6 (SLEN3). Genes Immun2002; 3: 57–62.
19.
ShaiRQuismorioFPJrLiL. Genome-wide screen for systemic lupus erythematosus susceptibility genes in multiplex families. Hum Molec Genet1999; 8: 639–644.
20.
JohannesonBLimaGvon SalomeJAlarcon-SegoviaDAlarcon-RiquelmeME. A major susceptibility locus for systemic lupus erythematosus maps to chromosome 1q31. Am J Hum Genet2002; 71: 1060–1071.
21.
RizzoRHviidTVFGovoniM. HLA-G genome and HLA-G expression in systemic lupus erythematosus: HLA-G as putative susceptibility gene in systemic lupus erythematosus. Tissue Antigens2008; 71: 520–529.
22.
VeitTDCorderoEAAMucenicT. Association of the HLA-G 14pb polymorphism with systemic lupus erythematosus. Lupus2009; 18: 424–430.
23.
PelletFSiannisFVukinILeePUrowitzMBGladmanDD. KIR and autoimmune disease: studies in systemic lupus erythematosus and scleroderma. Tissue Antigens2007; 69: 106–108.
24.
HouY-FZhangY-CJiaoY-L. Disparate distribution of activating and inhibitory killer cell immunoglobulin-like receptor genes in patients with systemic lupus erythematosus. Lupus2010; 19: 20–26.
25.
HochbergMC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum1997; 40: 1725–1725.
26.
SantosSEBGuerreiroJF. The indigenous contribution to the formation of the Population of the Brazilian Amazon Region. Genet Mol Biol1995; 18: 311–315.
27.
SantosNPRibeiro-RodriguesEMRibeiro-dos-SantosAK. Assessing individual interethnic admixture and population substructure using a 48-insertion-deletion (INSEL) ancestry-informative marker (AIM) panel. Hum Mutat2010; 31: 184–190.
28.
FrancoMHLP. Tipos de haptoglobina, hemoglobina e albumina em filarióticos e normais de Belém (PA). Master Dissertation, Universidade Federal do Rio Grande do Sul; 1973.
29.
AyresMSalzanoFMFrancoMHLPBarrosRMS. The association of blood groups, ABH secretion, haptoglobins and hemoglobins with filariasis. Hum Hered1976; 26: 105–109.
30.
SchneiderHSalzanoFM. Gm allotypes and racial admixture in two Brazilian population. Hum Genet1979; 53: 101–105.
31.
CorveloTCOSalzanoFM. New genetic data from an Amazonian town. Interciencia1984; 9: 236–238.
32.
GuerreiroJFChautard-Freire-MaiaEA. ABO and blood groups, migration and estimates of racial admixture for the population of Belem, State of Para, Brazil. Rev Bras Genet1988; 1: 171–186.
33.
SambrookJFritchEFManiatisT. Molecular Cloning: A Laboratory Manual. Cold Spring Harbor:Cold Spring Harbor Laboratory Press; 1989.
34.
HviidTVHyleniusSHoeghAMKruseCChristiansenOB. HLA-G polymorphism in couples with recurrent spontaneous abortions. Tissue Antigens2002; 60: 122–132.
35.
FrosstPBlomHJMilosR. A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nat Genet1995; 10: 111–113.
36.
SunTGaoYTanW. A six-nucleotide insertion-deletion polymorphism in the CASP8 promoter is associated with susceptibility to multiple cancers. Nat Genet2007; 39: 605–613.
37.
LiuJFujiwaraTMBuuNT. Identification of polymorphisms and sequence variants in human homologue of the mouse natural resistance-associated macrophage protein gene. Am J Hum Genet1995; 56: 845–853.
38.
MartinMPNelsonGLeeJH. Cutting edge: susceptibility to psoriatic arthritis: influence of activating Killer Ig-like Receptor genes in the absence of specific HLA-C alleles 1. J Immunol2002; 169: 2818–2822.
39.
FrohnCSchlenkePEbelBDannenbergCBeinGKirchnerH. DNA typing for natural killer cell inhibiting HLA-Cw groups NK1 and NK2 by PCR-SSP. J Immunol Meth1998; 218: 155–160.
40.
ShamPCCurtisD. Monte Carlo tests for associations between diseases and alleles at highly polymorphic loci. Ann Hum Genet1995; 59: 97–105.
41.
PritchardJKStephensMDonnellyP. Inference of population structure using multilocus genotype data. Genetics2000; 155: 945–959.
42.
PritchardJKStephensMRosenbergNADonnellyP. Association mapping in structured populations. Am J Hum Genet2000; 67: 170–181.
43.
FalushDStephensMPritchardJK. Inference of population structure using multilocus genotype data: linked loci and correlated allele frequencies. Genetics2003; 164: 1567–1587.
44.
FalushDStephensMPritchardJK. Inference of population structure using multilocus genotype data: dominant markers and null alleles. Mol Ecol Notes2007; 7: 574–578.
45.
SoborgCAndersenABRangeN. Influence of candidate susceptibility genes on tuberculosis in a high endemic region. Am J Clin Nutr2009; 90: 225–233.
46.
McDermidJMvan der LoeffMFJayeA. Mortality in HIV infection is independently predicted by host iron status and SLC11A1 and HP genotypes, with new evidence of a gene-nutrient interaction. Am J Clin Nutr2009; 90: 225–233.
47.
FitnessSFloydSWarndorffDK. Large-Scale candidate gene study of tuberculosis susceptibility in the Karonga district of northern Malawi. Am Trop Med Hyg2004; 71: 341–349.
48.
BellamyRMRCP, RuwendeC. Variations in the NRAMP1 gene and susceptibility to tuberculosis in West Africans. N Engl J Med1998; 5: 640–644.
49.
MeisnerSJMucklowSWarnerGSowSOLienhardtCHillAVS. Association of NRAMP1 polymorphism with leprosy type but not susceptibility to leprosy per se in West Africans. Am J Trop Med Hyg2001; 65: 733–735.
50.
DubaniewiczAJamiesonSEDubaniewicz-WybieralskaMFakiolaMNancy MillerEBlackwellJM. Association between SLC11A1 (formerly NRAMP1) and the risk of sarcoidosis in Poland. Eur J Hum Genet2005; 13: 829–834.
51.
SingalDPLiJZhuYZhangeG. NRAMP1 gene polymorphisms in patients with rheumatoid arthritis. Tissue Antigens2000; 55: 44–47.
52.
CeverraR. Systemic lupus erythematosus in Europe at the change of the millennium: Lessons from the “Euro-Lupus Project”. Autoimmun Rev2006; 5: 180–186.
53.
TiklyMNavarraSV. Lupus in the developing world – Is it any different?Best Pract Res Cl Rh2008; 5: 180–186.
54.
BlackwellJMBlackGFPacockCS. Immunogenetics of leishmanial and mycobacterial infections: the Belem Family study. Proc R Soc1997; 352: 1331–1345.
55.
O’BrienBAArcherNSSimpsonAMTorpyFRNassifNT. Association of SLC11A1 promoter polymorphisms with the incidence of autoimmune and inflammatory diseases: a meta-analysis. J Autoimmun2008; 31: 42–51.
56.
AtesODalyanLHatemiGHamuryudanVTopal-SarıkayaA. Genetic susceptibility to Behçet’s syndrome is associated with NRAMP1 (SLC11A1) polymorphism in Turkish patients. Rheumatol Int2009; 29: 787–791.
57.
AtesOMüsellimBÖngenGTopal-SarıkayaA. NRAMP1 (SLC11A1): a plausible candidate gene for Systemic Sclerosis (SSc) with Interstitial Lung Involvement. J Clin Immunol2008; 28: 73–77.
58.
YenJ-HLinC-HTsaiW-C. Natural resistance-associated macrophage protein 1 gene polymorphisms in rheumatoid arthritis. Immunol Lett2006; 102: 91–97.
59.
AtesODalyanLMüsellimB. NRAMP1 (SLC11A1) gene polymorphisms that correlate with autoimmune versus infectious disease susceptibility in tuberculosis and rheumatoid arthritis. Int J Immunogen2008; 36: 15–19.
60.
ZaahlMGRobsonKJHWarnichLKotzecMJ. Expression of the SLC11A1 (NRAMP1) 5V-(GT)n repeat: Opposite effect in the presence of -237C→T. Blood Cells Mol Dis2004; 33: 45–50.
61.
BayeleHKPeyssonnauxCGiatromanolakiA. HIF-1 regulates heritable variation and allele expression phenotypes of the macrophage immune response gene SLC11A1 from a Z-DNA–forming microsatellite. Phagocytes2007; 110: 3039–3048.
62.
StoberCBBrodeSWhiteJKPopoffJ-FBlackwellJM. Slc11a1, Formerly Nramp1, is expressed in dendritic cells and influences Major Histocompatibility Complex Class II expression and Antigen-Presenting Cell function. Infect Immun2007; 75: 5059–5067.
63.
KulkarniSMartinMPCarringtonM. The yin and yang of HLA and KIR in human disease. Semin Immunol2008; 20: 343–352.
64.
BasuDLiuYWuA. Stimulatory and inhibitory killer Ig-like receptor molecules are expressed and functional on Lupus T cells. J Immunol2009; 183: 3481–3487.
65.
Pante-de-SousaGMousinho-RibeiroRCSantosEJMZagoMAGuerreiroJF. Origin of the Hemoglobin S gene in a northern Brazilian population: The combined effects of slave trade and internal migration. Gen Mol Biol1998; 21: 427–430.
66.
TanEMCohenASFriesJF. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum1982; 25: 1271–1277.
